3.22.4 html 273 305 1 false 70 0 false 9 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.lavatherapeutics.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Consolidated statements of loss and other comprehensive loss Sheet http://www.lavatherapeutics.com/role/StatementConsolidatedStatementsOfLossAndOtherComprehensiveLoss Consolidated statements of loss and other comprehensive loss Statements 2 false false R3.htm 00200 - Statement - Consolidated statements of financial position Sheet http://www.lavatherapeutics.com/role/StatementConsolidatedStatementsOfFinancialPosition Consolidated statements of financial position Statements 3 false false R4.htm 00300 - Statement - Consolidated statements of changes in equity Sheet http://www.lavatherapeutics.com/role/StatementConsolidatedStatementsOfChangesInEquity Consolidated statements of changes in equity Statements 4 false false R5.htm 00305 - Statement - Consolidated statements of changes in equity (Parenthetical) Sheet http://www.lavatherapeutics.com/role/StatementConsolidatedStatementsOfChangesInEquityParenthetical Consolidated statements of changes in equity (Parenthetical) Statements 5 false false R6.htm 00400 - Statement - Consolidated statements of cash flows Sheet http://www.lavatherapeutics.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated statements of cash flows Statements 6 false false R7.htm 00405 - Statement - Consolidated statements of cash flows (Parenthetical) Sheet http://www.lavatherapeutics.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical Consolidated statements of cash flows (Parenthetical) Statements 7 false false R8.htm 10101 - Disclosure - Corporate and Company information Sheet http://www.lavatherapeutics.com/role/DisclosureCorporateAndCompanyInformation Corporate and Company information Notes 8 false false R9.htm 10201 - Disclosure - Summary of significant accounting policies Sheet http://www.lavatherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of significant accounting policies Notes 9 false false R10.htm 10301 - Disclosure - Significant accounting judgments, estimates and assumptions Sheet http://www.lavatherapeutics.com/role/DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptions Significant accounting judgments, estimates and assumptions Notes 10 false false R11.htm 10401 - Disclosure - Revenue Sheet http://www.lavatherapeutics.com/role/DisclosureRevenue Revenue Notes 11 false false R12.htm 10501 - Disclosure - Research and development expenses Sheet http://www.lavatherapeutics.com/role/DisclosureResearchAndDevelopmentExpenses Research and development expenses Notes 12 false false R13.htm 10601 - Disclosure - General and administrative expenses Sheet http://www.lavatherapeutics.com/role/DisclosureGeneralAndAdministrativeExpenses General and administrative expenses Notes 13 false false R14.htm 10701 - Disclosure - Interest expense, net Sheet http://www.lavatherapeutics.com/role/DisclosureInterestExpenseNet Interest expense, net Notes 14 false false R15.htm 10801 - Disclosure - Foreign currency exchange loss, net Sheet http://www.lavatherapeutics.com/role/DisclosureForeignCurrencyExchangeLossNet Foreign currency exchange loss, net Notes 15 false false R16.htm 10901 - Disclosure - Taxation Sheet http://www.lavatherapeutics.com/role/DisclosureTaxation Taxation Notes 16 false false R17.htm 11001 - Disclosure - Earnings per share (EPS) Sheet http://www.lavatherapeutics.com/role/DisclosureEarningsPerShareEps Earnings per share (EPS) Notes 17 false false R18.htm 11101 - Disclosure - Property and equipment Sheet http://www.lavatherapeutics.com/role/DisclosurePropertyAndEquipment Property and equipment Notes 18 false false R19.htm 11201 - Disclosure - Leases Sheet http://www.lavatherapeutics.com/role/DisclosureLeases Leases Notes 19 false false R20.htm 11301 - Disclosure - Investments Sheet http://www.lavatherapeutics.com/role/DisclosureInvestments Investments Notes 20 false false R21.htm 11401 - Disclosure - Cash and cash equivalents Sheet http://www.lavatherapeutics.com/role/DisclosureCashAndCashEquivalents Cash and cash equivalents Notes 21 false false R22.htm 11501 - Disclosure - Share capital, share premium and other capital reserves Sheet http://www.lavatherapeutics.com/role/DisclosureShareCapitalSharePremiumAndOtherCapitalReserves Share capital, share premium and other capital reserves Notes 22 false false R23.htm 11601 - Disclosure - Borrowings Sheet http://www.lavatherapeutics.com/role/DisclosureBorrowings Borrowings Notes 23 false false R24.htm 11701 - Disclosure - Trade payables and other Sheet http://www.lavatherapeutics.com/role/DisclosureTradePayablesAndOther Trade payables and other Notes 24 false false R25.htm 11801 - Disclosure - Working capital Sheet http://www.lavatherapeutics.com/role/DisclosureWorkingCapital Working capital Notes 25 false false R26.htm 11901 - Disclosure - Share-based compensation Sheet http://www.lavatherapeutics.com/role/DisclosureShareBasedCompensation Share-based compensation Notes 26 false false R27.htm 12001 - Disclosure - Related parties Sheet http://www.lavatherapeutics.com/role/DisclosureRelatedParties Related parties Notes 27 false false R28.htm 12101 - Disclosure - Financial instruments, risk management and capital management Sheet http://www.lavatherapeutics.com/role/DisclosureFinancialInstrumentsRiskManagementAndCapitalManagement Financial instruments, risk management and capital management Notes 28 false false R29.htm 12201 - Disclosure - Commitments and Contingencies Sheet http://www.lavatherapeutics.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 29 false false R30.htm 20202 - Disclosure - Summary of significant accounting policies (Policies) Sheet http://www.lavatherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of significant accounting policies (Policies) Policies 30 false false R31.htm 30103 - Disclosure - Corporate and Company information (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureCorporateAndCompanyInformationTables Corporate and Company information (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureCorporateAndCompanyInformation 31 false false R32.htm 30203 - Disclosure - Summary of significant accounting policies (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of significant accounting policies (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPolicies 32 false false R33.htm 30403 - Disclosure - Revenue (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureRevenueTables Revenue (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureRevenue 33 false false R34.htm 30503 - Disclosure - Research and development expenses (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureResearchAndDevelopmentExpensesTables Research and development expenses (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureResearchAndDevelopmentExpenses 34 false false R35.htm 30603 - Disclosure - General and administrative expenses (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureGeneralAndAdministrativeExpensesTables General and administrative expenses (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureGeneralAndAdministrativeExpenses 35 false false R36.htm 30703 - Disclosure - Interest expense, net (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureInterestExpenseNetTables Interest expense, net (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureInterestExpenseNet 36 false false R37.htm 30903 - Disclosure - Taxation (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureTaxationTables Taxation (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureTaxation 37 false false R38.htm 31003 - Disclosure - Earnings per share (EPS) (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureEarningsPerShareEpsTables Earnings per share (EPS) (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureEarningsPerShareEps 38 false false R39.htm 31103 - Disclosure - Property and equipment (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosurePropertyAndEquipmentTables Property and equipment (Tables) Tables http://www.lavatherapeutics.com/role/DisclosurePropertyAndEquipment 39 false false R40.htm 31203 - Disclosure - Leases (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureLeasesTables Leases (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureLeases 40 false false R41.htm 31403 - Disclosure - Cash and cash equivalents (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureCashAndCashEquivalentsTables Cash and cash equivalents (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureCashAndCashEquivalents 41 false false R42.htm 31503 - Disclosure - Share capital, share premium and other capital reserves (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureShareCapitalSharePremiumAndOtherCapitalReservesTables Share capital, share premium and other capital reserves (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureShareCapitalSharePremiumAndOtherCapitalReserves 42 false false R43.htm 31803 - Disclosure - Working capital (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureWorkingCapitalTables Working capital (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureWorkingCapital 43 false false R44.htm 31903 - Disclosure - Share-based compensation (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureShareBasedCompensationTables Share-based compensation (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureShareBasedCompensation 44 false false R45.htm 32003 - Disclosure - Related parties (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureRelatedPartiesTables Related parties (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureRelatedParties 45 false false R46.htm 32103 - Disclosure - Financial instruments, risk management and capital management (Tables) Sheet http://www.lavatherapeutics.com/role/DisclosureFinancialInstrumentsRiskManagementAndCapitalManagementTables Financial instruments, risk management and capital management (Tables) Tables http://www.lavatherapeutics.com/role/DisclosureFinancialInstrumentsRiskManagementAndCapitalManagement 46 false false R47.htm 40101 - Disclosure - Corporate and Company information (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureCorporateAndCompanyInformationDetails Corporate and Company information (Details) Details http://www.lavatherapeutics.com/role/DisclosureCorporateAndCompanyInformationTables 47 false false R48.htm 40201 - Disclosure - Summary of significant accounting policies (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of significant accounting policies (Details) Details http://www.lavatherapeutics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 48 false false R49.htm 40301 - Disclosure - Significant accounting judgments, estimates and assumptions (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptionsDetails Significant accounting judgments, estimates and assumptions (Details) Details http://www.lavatherapeutics.com/role/DisclosureSignificantAccountingJudgmentsEstimatesAndAssumptions 49 false false R50.htm 40401 - Disclosure - Revenue (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureRevenueDetails Revenue (Details) Details http://www.lavatherapeutics.com/role/DisclosureRevenueTables 50 false false R51.htm 40501 - Disclosure - Research and development expenses (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureResearchAndDevelopmentExpensesDetails Research and development expenses (Details) Details http://www.lavatherapeutics.com/role/DisclosureResearchAndDevelopmentExpensesTables 51 false false R52.htm 40601 - Disclosure - General and administrative expenses (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureGeneralAndAdministrativeExpensesDetails General and administrative expenses (Details) Details http://www.lavatherapeutics.com/role/DisclosureGeneralAndAdministrativeExpensesTables 52 false false R53.htm 40701 - Disclosure - Interest expense, net (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureInterestExpenseNetDetails Interest expense, net (Details) Details http://www.lavatherapeutics.com/role/DisclosureInterestExpenseNetTables 53 false false R54.htm 40801 - Disclosure - Foreign currency exchange loss, net (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureForeignCurrencyExchangeLossNetDetails Foreign currency exchange loss, net (Details) Details http://www.lavatherapeutics.com/role/DisclosureForeignCurrencyExchangeLossNet 54 false false R55.htm 40901 - Disclosure - Taxation (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureTaxationDetails Taxation (Details) Details http://www.lavatherapeutics.com/role/DisclosureTaxationTables 55 false false R56.htm 40902 - Disclosure - Taxation - Tax-losses carry forward (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureTaxationTaxLossesCarryForwardDetails Taxation - Tax-losses carry forward (Details) Details 56 false false R57.htm 41001 - Disclosure - Earnings per share (EPS) (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureEarningsPerShareEpsDetails Earnings per share (EPS) (Details) Details http://www.lavatherapeutics.com/role/DisclosureEarningsPerShareEpsTables 57 false false R58.htm 41101 - Disclosure - Property and equipment (Details) Sheet http://www.lavatherapeutics.com/role/DisclosurePropertyAndEquipmentDetails Property and equipment (Details) Details http://www.lavatherapeutics.com/role/DisclosurePropertyAndEquipmentTables 58 false false R59.htm 41201 - Disclosure - Leases (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureLeasesDetails Leases (Details) Details http://www.lavatherapeutics.com/role/DisclosureLeasesTables 59 false false R60.htm 41202 - Disclosure - Leases - Maturities of lease liabilities (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails Leases - Maturities of lease liabilities (Details) Details 60 false false R61.htm 41301 - Disclosure - Investments (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureInvestmentsDetails Investments (Details) Details http://www.lavatherapeutics.com/role/DisclosureInvestments 61 false false R62.htm 41401 - Disclosure - Cash and cash equivalents (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureCashAndCashEquivalentsDetails Cash and cash equivalents (Details) Details http://www.lavatherapeutics.com/role/DisclosureCashAndCashEquivalentsTables 62 false false R63.htm 41501 - Disclosure - Share capital, share premium and other capital reserves - Summary (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureShareCapitalSharePremiumAndOtherCapitalReservesSummaryDetails Share capital, share premium and other capital reserves - Summary (Details) Details http://www.lavatherapeutics.com/role/DisclosureShareCapitalSharePremiumAndOtherCapitalReservesTables 63 false false R64.htm 41502 - Disclosure - Share capital, share premium and other capital reserves - Preference share (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureShareCapitalSharePremiumAndOtherCapitalReservesPreferenceShareDetails Share capital, share premium and other capital reserves - Preference share (Details) Details 64 false false R65.htm 41503 - Disclosure - Share capital, share premium and other capital reserves - Common shares (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureShareCapitalSharePremiumAndOtherCapitalReservesCommonSharesDetails Share capital, share premium and other capital reserves - Common shares (Details) Details 65 false false R66.htm 41504 - Disclosure - Share capital, share premium and other capital reserves - Major shareholders (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureShareCapitalSharePremiumAndOtherCapitalReservesMajorShareholdersDetails Share capital, share premium and other capital reserves - Major shareholders (Details) Details 66 false false R67.htm 41601 - Disclosure - Borrowings (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureBorrowingsDetails Borrowings (Details) Details http://www.lavatherapeutics.com/role/DisclosureBorrowings 67 false false R68.htm 41701 - Disclosure - Trade payables and other (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureTradePayablesAndOtherDetails Trade payables and other (Details) Details http://www.lavatherapeutics.com/role/DisclosureTradePayablesAndOther 68 false false R69.htm 41801 - Disclosure - Working capital - Prepaid expenses and other current assets (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureWorkingCapitalPrepaidExpensesAndOtherCurrentAssetsDetails Working capital - Prepaid expenses and other current assets (Details) Details 69 false false R70.htm 41802 - Disclosure - Working capital - Accrued expenses and other current liabilities (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureWorkingCapitalAccruedExpensesAndOtherCurrentLiabilitiesDetails Working capital - Accrued expenses and other current liabilities (Details) Details 70 false false R71.htm 41901 - Disclosure - Share-based compensation - Number of option and exercise price (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureShareBasedCompensationNumberOfOptionAndExercisePriceDetails Share-based compensation - Number of option and exercise price (Details) Details 71 false false R72.htm 41902 - Disclosure - Share-based compensation - Fair value measurement (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureShareBasedCompensationFairValueMeasurementDetails Share-based compensation - Fair value measurement (Details) Details 72 false false R73.htm 41903 - Disclosure - Share-based compensation - Narratives (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureShareBasedCompensationNarrativesDetails Share-based compensation - Narratives (Details) Details 73 false false R74.htm 42001 - Disclosure - Related parties - Key management compensation (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureRelatedPartiesKeyManagementCompensationDetails Related parties - Key management compensation (Details) Details 74 false false R75.htm 42002 - Disclosure - Related parties - Director and shareholder compensation (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureRelatedPartiesDirectorAndShareholderCompensationDetails Related parties - Director and shareholder compensation (Details) Details 75 false false R76.htm 42101 - Disclosure - Financial instruments, risk management and capital management (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureFinancialInstrumentsRiskManagementAndCapitalManagementDetails Financial instruments, risk management and capital management (Details) Details http://www.lavatherapeutics.com/role/DisclosureFinancialInstrumentsRiskManagementAndCapitalManagementTables 76 false false R77.htm 42201 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.lavatherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.lavatherapeutics.com/role/DisclosureCommitmentsAndContingencies 77 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 17 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, ifrs-full:AdjustedWeightedAverageShares, ifrs-full:DilutedEarningsLossPerShare, ifrs-full:FinancialAssets, lvtx:ResearchAndLicenseAgreementRoyaltiesPayableYearsOfSale, lvtx:TermOfResearchAndLicenseAgreement - lvtx-20211231x20fa.htm 9 lvtx-20211231x20fa.htm lvtx-20211231.xsd lvtx-20211231_cal.xml lvtx-20211231_def.xml lvtx-20211231_lab.xml lvtx-20211231_pre.xml lvtx-20211231xex12d1.htm lvtx-20211231xex12d2.htm lvtx-20211231xex13d1.htm lvtx-20211231xex13d2.htm lvtx-20211231x20fa001.jpg lvtx-20211231x20fa002.jpg lvtx-20211231x20fa003.jpg lvtx-20211231x20fa004.jpg http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full http://xbrl.sec.gov/dei/2021q4 true true